|
Efficacy of microwave ablation therapy for uterine fibroids
|
J. Zhao   , W. Chen , C. Li , H. Xiao , Y. Jin , Y. Wang , J. Gao |
| Department of Obstetrics and Gynecology, Beijing Luhe Hospital, Capital Medical University, Beijing, China , yjsjy1981@126.com |
|
|
Abstract: (290 Views) |
Background: To investigate the efficacy of laparoscopic combined with microwave ablation therapy in treating multiple uterine fibroids and its impact on patients' quality of life. Materials and Methods: This study included a total of 100 patients with uterine fibroids, divided into a laparoscopic group (50 cases) and a laparoscopic combined with microwave ablation group (50 cases), treated with either laparoscopic surgery alone or laparoscopic combined with microwave ablation therapy. General information of the patients, MRI images before and after treatment, contrast-enhanced ultrasound before and after treatment, intraoperative blood loss, operation time, length of hospital stay, time to postoperative ambulation, VAS score, and ovarian function were collected and analyzed. Results: Compared with laparoscopic surgery alone, the laparoscopic combined with microwave ablation group had lower postoperative pain scores, less intraoperative blood loss, and faster postoperative recovery. There was no significant difference in ovarian function indicators after surgery compared with before surgery, indicating no difference in ovarian function and reserve between the two surgical methods. Additionally, the total effective rate of the combined treatment group reached 98%, significantly higher than the 92% in the laparoscopic group. Imaging analysis showed that the structure of surrounding tissues and vascular layout were restored closer to the normal state after combined treatment. Conclusion: Laparoscopic combined with microwave ablation therapy shows superior efficacy and safety in treating multiple uterine fibroids compared to laparoscopic surgery alone, making it an effective method for treating multiple uterine fibroids, worthy of further clinical promotion and application. |
|
| Keywords: Uterine fibroids, leiomyoma, laparoscopy, microwave ablation. |
|
|
Full-Text [PDF 771 kb]
(66 Downloads)
|
|
Type of Study: Original Research |
Subject:
Radiation Biology
|
|
|
|
|
|
|
| References |
1. Perez-Lopez FR, Ornat L, Ceausu I, et al. (2014) EMAS position statement: management of uterine fibroids. Maturitas, 79(1): 106-116. [ DOI:10.1016/j.maturitas.2014.06.002] 2. Puchar A, Feyeux C, Luton D, Koskas M (2016) Therapeutic management of uterine fibroid tumors. Minerva Ginecologica, 68(4): 466-476. 3. Donnez J and Dolmans MM (2016) Uterine fibroid management: from the present to the future. Hum Reprod Update, 22(6): 665-686. [ DOI:10.1093/humupd/dmw023] 4. Rutanen EM (2000) Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery. Human Reproduction, 15 (Suppl 3): 173-181. [ DOI:10.1093/humrep/15.suppl_3.173] 5. Zhou J, Dsupin BA, Giudice LC, Bondy CA (1994) Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. Journal of Clinical Endocrinology & Metabolism, 79(6): 1723-1734. [ DOI:10.1210/jcem.79.6.7527408] 6. Iavazzo C, Mamais I, Gkegkes ID (2016) Robotic assisted vs laparoscopic and/or open myomectomy: systematic review and meta-analysis of the clinical evidence. Arch Gynecol Obstet, 294(1): 5-17. [ DOI:10.1007/s00404-016-4061-6] 7. Han VK, Carter AM, Chandarana S, Tanswell B, Thompson K (1999) Ontogeny of expression of insulin-like growth factor (IGF) and IGF binding protein mRNAs in the guinea-pig placenta and uterus. Placenta, 20(4): 361-377. [ DOI:10.1053/plac.1998.0389] 8. Csatlos E, Rigo JJ, Laky M, Joo JG (2013) Gene expression patterns of insulin-like growth factor 2 in human uterine fibroid tissues: a genetic study with clinical correlations. Gynecologic and Obstetric Investigation, 75(3): 185-190. [ DOI:10.1159/000347017] 9. Csatlós E, Rigó J Jr, Laky M, Joó JG (2013) Gene expression patterns of insulin-like growth factor 2 in human uterine fibroid tissues: a genetic study with clinical correlations. Gynecol Obstet Invest, 75(3): 185-190. [ DOI:10.1159/000347017] 10. Gloudemans T, Prinsen I, Van Unnik JA, Lips CJ, Den Otter W, Sussenbach JS (1990) Insulin-like growth factor gene expression in human smooth muscle tumors. Cancer Research, 50(20): 6689-6695. 11. Han VK, Bassett N, Walton J, Challis JR (1996) The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Journal of Clinical Endocrinology & Metabolism, 81(7): 2680-2693. [ DOI:10.1210/jcem.81.7.8675597] 12. Tang H, Dong Z, Qin Z, et al. (2022) Preliminary Analysis of Safety and Feasibility of a Single-Hole Laparoscopic Myomectomy via an Abdominal Scar Approach. Frontiers in Surgery, 9(916792. [ DOI:10.3389/fsurg.2022.916792] 13. Qin S, Jiang Y, Wang F, Tang L, Huang X (2023) Development and validation of a combined model based on dual-sequence MRI radiomics for predicting the efficacy of high-intensity focused ultrasound ablation for hysteromyoma. International Journal of Hyperthermia, 40(1): 2149862. [ DOI:10.1080/02656736.2022.2149862] 14. Liu L, Xiao YH, Zhou XH (2023) Effects of humanized nursing care on negative emotions and complications in patients undergoing hysteromyoma surgery. World Journal of Clinical Cases, 11(28): 6763-6773. [ DOI:10.12998/wjcc.v11.i28.6763] 15. McDonald S, Page MJ, Beringer K, Wasiak J, Sprowson A (2014) Preoperative education for hip or knee replacement. Cochrane Database of Systematic Reviews, 2014(5): CD003526. [ DOI:10.1002/14651858.CD003526.pub3] 16. Dai Y, Chen H, Yu J, et al. (2024) Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: A worldwide database study. Chinese Medical Journal, 137(21): 2583-2589. [ DOI:10.1097/CM9.0000000000002971] 17. Tomas CC, Oliveira E, Sousa D, et al. (2016) Proceedings of the 3rd IPLeiria's International Health Congress: Leiria, Portugal. 6-7 May 2016. BMC Health Services Research, 16 Suppl 3(Suppl 3): 200. 18. Gracia M, Rius M, Carmona F (2023) Clinical relevance of uterine fibroids: Epidemiology, risk and protective factors, and pathophysiology. Medicina Clinica, 161 (Suppl 1): S1-S4. [ DOI:10.1016/j.medcli.2023.06.033] 19. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH (2012) The estimated annual cost of uterine leiomyomata in the United States. American Journal of Obstetrics and Gynecology, 206(3): 211. [ DOI:10.1016/j.ajog.2011.12.002] 20. Peddada SD, Laughlin SK, Miner K, et al. (2008) Growth of uterine leiomyomata among premenopausal black and white women. Proceedings of the National Academy of Sciences of the United States of America, 105(50): 19887-19892. [ DOI:10.1073/pnas.0808188105] 21. Vilos GA, Allaire C, Laberge PY, Leyland N (2015) The management of uterine leiomyomas. Journal of Obstetrics and Gynaecology Canada, 37(2): 157-178. [ DOI:10.1016/S1701-2163(15)30338-8] 22. Yuk JS, Cho IC, Lee JH (2023) the risk of stress urinary incontinence after hysterectomy for uterine fibroids. International Neurourology Journal, 27(4): 252-259. [ DOI:10.5213/inj.2346192.096] 23. Baessler K, Christmann-Schmid C, Maher C, Haya N, Crawford TJ, Brown J (2018) Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database of Systematic Reviews, 8(8): CD013108. [ DOI:10.1002/14651858.CD013108] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Zhao J, Chen W, Li C, Xiao H, Jin Y, Wang Y et al . Efficacy of microwave ablation therapy for uterine fibroids. Int J Radiat Res 2025; 23 (1) :91-96 URL: http://ijrr.com/article-1-5964-en.html
|
